Citations (227)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (35)
Dahiana M. Gallo, Wendy Fitzgerald, Roberto Romero, Nardhy Gomez-Lopez, Dereje W. Gudicha, Nándor Gábor Than, Mariachiara Bosco, Tinnakorn Chaiworapongsa, Eunjung Jung, Arun Meyyazhagan, Manaphat Suksai, Francesca Gotsch, Offer Erez, Adi L. Tarca & Leonid Margolis. (2023) Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death. The Journal of Maternal-Fetal & Neonatal Medicine 36:1.
Read now
Read now
Sun Kwon Kim, Sangeetha Vishweswaraiah, Jacqueline Macknis, Ali Yilmaz, Ashna Lalwani, Nitish K. Mishra, Chittibabu Guda, Dotun Ogunyemi, Uppala Radhakrishna & Ray O. Bahado-Singh. (2022) New-onset postpartum preeclampsia: epigenetic mechanism and prediction. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 7179-7187.
Read now
Read now
Bogdan Panaitescu, Roberto Romero, Nardhy Gomez-Lopez, Percy Pacora, Offer Erez, Felipe Vadillo-Ortega, Lami Yeo, Sonia S. Hassan & Chaur-Dong Hsu. (2020) ELABELA plasma concentrations are increased in women with late-onset preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 33:1, pages 5-15.
Read now
Read now
Nikolina Docheva, Roberto Romero, Piya Chaemsaithong, Adi L. Tarca, Gaurav Bhatti, Percy Pacora, Bogdan Panaitescu, Noppadol Chaiyasit, Tinnakorn Chaiworapongsa, Eli Maymon, Sonia S. Hassan & Offer Erez. (2019) The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*. The Journal of Maternal-Fetal & Neonatal Medicine 32:13, pages 2113-2136.
Read now
Read now
Lina A. Dahabiyeh. (2018) The discovery of protein biomarkers in pre-eclampsia: the promising role of mass spectrometry. Biomarkers 23:7, pages 609-621.
Read now
Read now
Kristina Kumer, Tanja Premru-Sršen, Vesna Fabjan-Vodušek, Nataša Tul, Teja Fabjan & Joško Osredkar. (2018) Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia. Hypertension in Pregnancy 37:4, pages 197-203.
Read now
Read now
Roberto Romero, Piya Chaemsaithong, Adi L. Tarca, Steven J. Korzeniewski, Eli Maymon, Percy Pacora, Bogdan Panaitescu, Noppadol Chaiyasit, Zhong Dong, Offer Erez, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2018) Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia – a longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine 31:4, pages 418-432.
Read now
Read now
Ana Jakovljevic, Mirjana Bogavac, Zagorka Lozanov-Crvenkovic, Mirjana Milosević-Tosic, Aleksandra Nikolic & Gorana Mitic. (2017) Early pregnancy angiogenic proteins levels and pregnancy related hypertensive disorders. The Journal of Maternal-Fetal & Neonatal Medicine 30:5, pages 534-539.
Read now
Read now
Sebastian Kwiatkowski, Ewa Kwiatkowska, Rafał Rzepka, Andrzej Torbe & Barbara Dolegowska. (2016) Ischemic placental syndrome – prediction and new disease monitoring. The Journal of Maternal-Fetal & Neonatal Medicine 29:12, pages 2033-2039.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Amy E. Whitten, Steven J. Korzeniewski, Piya Chaemsaithong, Edgar Hernandez-Andrade, Lami Yeo & Sonia S. Hassan. (2016) The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 29:8, pages 1214-1228.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Piya Chaemsaithong, Edgar Hernandez-Andrade, James H. Segars, Alan H. DeCherney, M. Cathleen McCoy, Chong Jai Kim, Lami Yeo & Sonia S. Hassan. (2016) Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). The Journal of Maternal-Fetal & Neonatal Medicine 29:6, pages 855-862.
Read now
Read now
Sara Zullino, Daniela Di Martino, Tamara Stampalija & Enrico Ferrazzi. (2016) New lenses to look at preeclampsia. Gynecological Endocrinology 32:2, pages 87-90.
Read now
Read now
Piya Chaemsaithong, Roberto Romero, Adi L. Tarca, Steven J. Korzeniewski, Alyse G. Schwartz, Jezid Miranda, Ahmed I. Ahmed, Zhong Dong, Sonia S. Hassan, Lami Yeo & Tinnakorn Tinnakorn. (2015) Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine 28:11, pages 1260-1269.
Read now
Read now
Thushari I. Alahakoon, Weiyi Zhang, Brian J. Trudinger & Vincent W. Lee. (2014) Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles. The Journal of Maternal-Fetal & Neonatal Medicine 27:18, pages 1854-1859.
Read now
Read now
Kedak Baltajian, Jonathan L. Hecht, Julia B. Wenger, Saira Salahuddin, Stefan Verlohren, Frank H. Perschel, Zsuzsanna K. Zsengeller, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2014) Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertension in Pregnancy 33:4, pages 427-439.
Read now
Read now
Tiffany A. Moore Simas, Sybil L. Crawford, Susanne Bathgate, Jing Yan, Laura Robidoux, Melissa Moore & Sharon E. Maynard. (2014) Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. The Journal of Maternal-Fetal & Neonatal Medicine 27:10, pages 1038-1048.
Read now
Read now
Ratko Delić, Mario Štefanović, Štefka Krivec & Vladimir Weber. (2014) Statistical regression model of standard and new laboratory markers and its usefulness in prediction of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 27:4, pages 388-392.
Read now
Read now
Allison L. Cohen, Julia B. Wenger, Tamarra James-Todd, Brooke M. Lamparello, Elizabeth Halprin, Shanti Serdy, Shuling Fan, Gary L. Horowitz, Kee-Hak Lim, Sarosh Rana, Tamara C. Takoudes, Jennifer A. Wyckoff, Ravi Thadhani, S. Ananth Karumanchi & Florence M. Brown. (2014) The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertension in Pregnancy 33:1, pages 81-92.
Read now
Read now
Hironori Takahashi, Michi Hisano, Haruhiko Sago, Atsuko Murashima & Koushi Yamaguchi. (2014) Hypoproteinemia in the second trimester among patients with preeclampsia prior to the onset of clinical symptoms. Hypertension in Pregnancy 33:1, pages 55-60.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Read now
Tamara Stampalija, Tinnakorn Chaiworapongsa, Roberto Romero, Piya Chaemsaithong, Steven J. Korzeniewski, Alyse G. Schwartz, Enrico M. Ferrazzi, Zhong Dong & Sonia S. Hassan. (2013) Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 26:14, pages 1359-1370.
Read now
Read now
Nikolaos Vrachnis, Emmanouil Kalampokas, Stavros Sifakis, Nikolaos Vitoratos, Theodoros Kalampokas, Demetrios Botsis & Zoe Iliodromiti. (2013) Placental growth factor (PlGF): a key to optimizing fetal growth. The Journal of Maternal-Fetal & Neonatal Medicine 26:10, pages 995-1002.
Read now
Read now
Shin Young Kim, So Yeon Park, Mi Jin Kim, Bom Yi Lee, Jung Yeol Han & Hyun Mee Ryu. (2013) Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester. The Journal of Maternal-Fetal & Neonatal Medicine 26:9, pages 860-865.
Read now
Read now
Sarosh Rana, William T. Schnettler, Camille Powe, Julia Wenger, Saira Salahuddin, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Zoltan Arany, Kee-Hak Lim, Ravi Thadhani & S. Ananth Karumanchi. (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertension in Pregnancy 32:2, pages 189-201.
Read now
Read now
Tamar Eshkoli, Gershon Holcberg, Bella Bronfenmacher, Alaa Amash, Mahmoud Huleihel & Offer Erez. (2013) Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 26:2, pages 116-122.
Read now
Read now
Andreea G. Moore, Heather Young, Jennifer M. Keller, Linda R. Ojo, Jing Yan, Tiffany A. Moore Simas & Sharon E. Maynard. (2012) Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 25:12, pages 2651-2657.
Read now
Read now
Jimmy Espinoza. (2012) The need to redefine preeclampsia. Expert Opinion on Medical Diagnostics 6:4, pages 347-357.
Read now
Read now
L. M. Reyes, R. G. García, S. L. Ruiz, D. Broadhurst, G. Aroca, S. T. Davidge & P. López-Jaramillo. (2012) Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country. Growth Factors 30:3, pages 158-166.
Read now
Read now
Eleazar Soto, Roberto Romero, Juan Pedro Kusanovic, Giovanna Ogge, Youssef Hussein, Lami Yeo, Sonia S Hassan, Chong Jai Kim & Tinnakorn Chaiworapongsa. (2012) Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. The Journal of Maternal-Fetal & Neonatal Medicine 25:5, pages 498-507.
Read now
Read now
Jimmy Espinoza. (2012) Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia. Expert Opinion on Medical Diagnostics 6:2, pages 121-130.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Zeynep Alpay Savasan, Juan Pedro Kusanovic, Giovanna Ogge, Eleazar Soto, Zhong Dong, Adi Tarca, Bhatti Gaurav & Sonia S. Hassan. (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 24:10, pages 1187-1207.
Read now
Read now
Roberto Romero, Tinnakorn Chaiworapongsa, Offer Erez, Adi L. Tarca, Maria Teresa Gervasi, Juan Pedro Kusanovic, Pooja Mittal, Giovanna Ogge, Edi Vaisbuch, Shali Mazaki-Tovi, Zhong Dong, Sun Kwon Kim, Lami Yeo & Sonia S. Hassan. (2010) An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine 23:12, pages 1384-1399.
Read now
Read now
Hisashi Masuyama & Yuji Hiramatsu. (2010) Angiogenic proteins and adipocytokines as markers for prediction of preeclampsia. Expert Review of Obstetrics & Gynecology 5:6, pages 717-725.
Read now
Read now
Giovanna Oggé, Roberto Romero, Tinnakorn Chaiworapongsa, Maria Teresa Gervasi, Percy Pacora, Offer Erez, Juan Pedro Kusanovic, Edi Vaisbuch, Shali Mazaki-Tovi, Francesca Gotsch, Pooja Mittal, Yeon Mee Kim & Sonia S. Hassan. (2010) Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 23:6, pages 476-487.
Read now
Read now
Ana Sofia Cerdeira & S. Ananth Karumanchi. (2010) Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia. Scandinavian Journal of Clinical and Laboratory Investigation 70:sup242, pages 73-78.
Read now
Read now
Articles from other publishers (192)
Iaroslav Youssim, Offer Erez, Lena Novack, Daniel Nevo, Itai Kloog & Raanan Raz. (2023) Ambient temperature and preeclampsia: A historical cohort study. Environmental Research 238, pages 117107.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Crossref
B. Villanueva, P. Cerdà, R. Torres-Iglesias, J.L. Rocamora, A. Figueras, F. Viñals & A. Riera-Mestre. (2023) Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases. European Journal of Internal Medicine 115, pages 10-17.
Crossref
Crossref
Piya Chaemsaithong, María M. Gil, Noppadol Chaiyasit, Diana Cuenca-Gomez, Walter Plasencia, Valeria Rolle & Liona C. Poon. (2023) Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 229:3, pages 222-247.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Crossref
Courtney Bisson, Sydney Dautel, Easha Patel, Sunitha Suresh, Patricia Dauer & Sarosh Rana. (2023) Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Frontiers in Medicine 10.
Crossref
Crossref
Weronika Dymara-Konopka, Marzena Laskowska, Ewelina Grywalska, Anna Hymos, Anna Błażewicz & Bożena Leszczyńska-Gorzelak. (2023) Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction. International Journal of Molecular Sciences 24:2, pages 972.
Crossref
Crossref
Mitchell L. Onslow, Jennifer Wolsk, Stephen Wisniewski, Sanjay Patel, Marcia Gallaher, Carl Hubel, David J. Cashmere & Francesca L. Facco. (2023) The association between sleep-disordered breathing and maternal endothelial and metabolic markers in pregnancies complicated by obesity. Journal of Clinical Sleep Medicine 19:1, pages 97-109.
Crossref
Crossref
Adi L. Tarca, Roberto Romero, Gaurav Bhatti, Francesca Gotsch, Bogdan Done, Dereje W. Gudicha, Dahiana M. Gallo, Eunjung Jung, Roger Pique-Regi, Stanley M. Berry, Tinnakorn Chaiworapongsa & Nardhy Gomez-Lopez. (2022) Human Plasma Proteome During Normal Pregnancy. Journal of Proteome Research 21:11, pages 2687-2702.
Crossref
Crossref
Marianna Danielli, Roisin C. Thomas, Clare L. Gillies, Jiamiao Hu, Kamlesh Khunti & Bee Kang Tan. (2022) Blood biomarkers to predict the onset of pre-eclampsia: A systematic review and meta-analysis. Heliyon 8:11, pages e11226.
Crossref
Crossref
Roberto Romero, Eunjung Jung, Tinnakorn Chaiworapongsa, Offer Erez, Dereje W. Gudicha, Yeon Mee Kim, Jung-Sun Kim, Bomi Kim, Juan Pedro Kusanovic, Francesca Gotsch, Andreea B. Taran, Bo Hyun Yoon, Sonia S. Hassan, Chaur-Dong Hsu, Piya Chaemsaithong, Nardhy Gomez-Lopez, Lami Yeo, Chong Jai Kim & Adi L. Tarca. (2022) Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. American Journal of Obstetrics and Gynecology 227:4, pages 615.e1-615.e25.
Crossref
Crossref
Nikolina Docheva, Gabriel Arenas, Kristin M Nieman, Joana Lopes-Perdigao, Kiang-Teck J Yeo & Sarosh Rana. (2022) Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia. Clinical Chemistry 68:6, pages 771-781.
Crossref
Crossref
Offer Erez, Roberto Romero, Eunjung Jung, Piya Chaemsaithong, Mariachiara Bosco, Manaphat Suksai, Dahiana M. Gallo & Francesca Gotsch. (2022) Preeclampsia and eclampsia: the conceptual evolution of a syndrome. American Journal of Obstetrics and Gynecology 226:2, pages S786-S803.
Crossref
Crossref
Eunjung Jung, Roberto Romero, Lami Yeo, Nardhy Gomez-Lopez, Piya Chaemsaithong, Adithep Jaovisidha, Francesca Gotsch & Offer Erez. (2022) The etiology of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S844-S866.
Crossref
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Crossref
Stefan Verlohren & Lisa-Antonia Dröge. (2022) The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S1048-S1058.
Crossref
Crossref
盈 丁. (2022) Correlation of sFlt-1/PlGF and Placental CD146 with Preeclampsia. Advances in Clinical Medicine 12:09, pages 8294-8304.
Crossref
Crossref
Adi L. Tarca, Andreea Taran, Roberto Romero, Eunjung Jung, Carmen Paredes, Gaurav Bhatti, Corina Ghita, Tinnakorn Chaiworapongsa, Nandor Gabor Than & Chaur-Dong Hsu. (2022) Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. American Journal of Obstetrics and Gynecology 226:1, pages 126.e1-126.e22.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2022. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
165
185
.
Miroslaw Wielgoś & Przemyslaw Kosinski. 2021. The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology. The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
139
146
.
Jing Zhu, Jun Zhang, Nurul Syaza Razali, Bernard Chern & Kok Hian Tan. (2021) Mean arterial pressure for predicting preeclampsia in Asian women: a longitudinal cohort study. BMJ Open 11:8, pages e046161.
Crossref
Crossref
Juilee S. Deshpande, Deepali P. Sundrani, Akriti S. Sahay, Sanjay A. Gupte & Sadhana R. Joshi. (2021) Unravelling the potential of angiogenic factors for the early prediction of preeclampsia. Hypertension Research 44:7, pages 756-769.
Crossref
Crossref
Bethel Woldu, Lochan M. Shah, Angela K. Shaddeau, Erin Goerlich, Sammy Zakaria, Allison G. Hays, Arthur J. Vaught, Andreea A. Creanga, Roger S. Blumenthal & Garima Sharma. (2021) The Role of Biomarkers and Imaging to Predict Preeclampsia and Subsequent Cardiovascular Dysfunction. Current Treatment Options in Cardiovascular Medicine 23:6.
Crossref
Crossref
Yuhui Zhang, Litao Huang, Dandan Wang, Pengwei Ren, Qi Hong & Deying Kang. (2021) The ROBINS‐I and the NOS had similar reliability but differed in applicability: A random sampling observational studies of systematic reviews/meta‐analysis. Journal of Evidence-Based Medicine 14:2, pages 112-122.
Crossref
Crossref
Jing He, Kang Liu, Xiaohong HouJieqiang Lu. (2021) Identification and validation of key non-coding RNAs and mRNAs using co-expression network analysis in pre-eclampsia. Medicine 100:14, pages e25294.
Crossref
Crossref
R. Nirupama, S. Divyashree, P. Janhavi, S.P. Muthukumar & P.V. Ravindra. (2021) Preeclampsia: Pathophysiology and management. Journal of Gynecology Obstetrics and Human Reproduction 50:2, pages 101975.
Crossref
Crossref
Nan Liu, Yu-Na Guo, Li-Kun Gong & Bing-Shun Wang. (2021) Advances in biomarker development and potential application for preeclampsia based on pathogenesis. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 9, pages 100119.
Crossref
Crossref
Pooneh Nikuei, Minoo Rajaei, Nasibeh Roozbeh, Fatemeh Mohseni, Fatemeh Poordarvishi, Mohsen Azad & Solmaz Haidari. (2020) Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsia. BMC Pregnancy and Childbirth 20:1.
Crossref
Crossref
Akihide Ohkuchi, Eiji Kondoh, Tatsuo Yamamoto, Hiroyuki Seki, Shigeru Saito, Shintaro Makino, Miwa NishidaTakashi Kikuchi. (2020) Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage. Hypertension Research in Pregnancy 8:2, pages 51-56.
Crossref
Crossref
. (2020) Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology 135:6, pages e237-e260.
Crossref
Crossref
Sagi Shashar, Itai Kloog, Offer Erez, Alexandra Shtein, Maayan Yitshak-Sade, Batia Sarov & Lena Novack. (2020) Temperature and preeclampsia: Epidemiological evidence that perturbation in maternal heat homeostasis affects pregnancy outcome. PLOS ONE 15:5, pages e0232877.
Crossref
Crossref
Jing Tian, Yamin Liu, Mingyu Hu, Yangxi Zheng, Ping Xu, Lan Zhang, Jiujiang Liao, Yue Wu, Li Wen, Chao Tong, Jianying Yan, Hongbo Qi, Richard Saffery, Philip N. Baker & Mark D. Kilby. (2020) Upregulated LncZBTB39 in pre-eclampsia and its effects on trophoblast invasion and migration via antagonizing the inhibition of miR-210 on THSD7A expression. European Journal of Obstetrics & Gynecology and Reproductive Biology 248, pages 164-171.
Crossref
Crossref
Anandita Umapathy, Lawrence W. Chamley & Joanna L. James. (2019) Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies. Angiogenesis 23:2, pages 105-117.
Crossref
Crossref
Kelly-Ann Eastwood, Alyson J Hunter, Christopher C Patterson, David R Mc Cance, Ian S Young & Valerie A Holmes. (2019) The role of biomarkers in predicting pre-eclampsia in high-risk women. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 57:2, pages 128-137.
Crossref
Crossref
Iryna Borysivna Borzenko. (2020) ROLE OF GESTATIONAL ENDOTHELIALOPATHY IN DEVELOPMENT OF INTRAUTERINE GROWTH RESTRICTION IN PREGNANT WOMEN WITH PLACENTAL DYSFUNCTION. International Medical Journal:3, pages 33-37.
Crossref
Crossref
Swati AgrawalShiri ShinarAna Sofia CerdeiraChristopher RedmanManu Vatish. (2019) Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women. Hypertension 74:5, pages 1124-1135.
Crossref
Crossref
Henri Boulanger, Guillaume Lefèvre, Salima Ahriz Saksi, Jedjiga Achiche, Sophie Bailleul, Dieudonné Ekoukou, Dominique Drouin, Corinne Sault, Nicolas Stawiarski & Emmanuel Dupuis. (2019) Intérêts potentiels des facteurs angiogéniques placentaires comme biomarqueurs dans la pré-éclampsie pour le clinicien. Néphrologie & Thérapeutique 15:6, pages 413-429.
Crossref
Crossref
Makmur Sitepu & Jusuf Rachmadsyah. 2019. Prediction of Maternal and Fetal Syndrome of Preeclampsia. Prediction of Maternal and Fetal Syndrome of Preeclampsia.
J Espinoza, A Betancourt, MA Belfort, AA Shamshirsaz, KA Fox & C Yallampalli. (2019) Placental growth factor blunts uterine artery responses to angiotensin II. BJOG: An International Journal of Obstetrics & Gynaecology 126:8, pages 1058-1064.
Crossref
Crossref
Anshul Jadli, Kanjaksha Ghosh, Kaizad Damania, Purnima Satoskar, Vandana Bansal & Shrimati Shetty. (2019) Prediction of preeclampsia using combination of biomarkers at 18–23 weeks of gestation: A nested case-control study. Pregnancy Hypertension 17, pages 20-27.
Crossref
Crossref
Laszlo Orosz, Gergo Orosz, Lajos Veress, Diana Dosa, Laszlo Orosz Sr, Ibolya Arany, Antal Fabian, Laszlo Medve, Karoly Pap, Zsolt Karanyi, Zoltan Toth, Robert Poka, Nandor Gabor Than & Olga Torok. (2019) Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary. Journal of Biotechnology 300, pages 11-19.
Crossref
Crossref
Adi L. Tarca, Roberto Romero, Neta Benshalom-Tirosh, Nandor Gabor Than, Dereje W. Gudicha, Bogdan Done, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Panaitescu, Dan Tirosh, Nardhy Gomez-Lopez, Sorin Draghici, Sonia S. Hassan & Offer Erez. (2019) The prediction of early preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 14:6, pages e0217273.
Crossref
Crossref
Qiu Ju Ng, Jonathan Youxiang Han, Seyed Ehsan Saffari, George Seow-Heong Yeo, Bernard Su Min Chern & Kok Hian Tan. (2019) Longitudinal circulating placental growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1) concentrations during pregnancy in Asian women: a prospective cohort study. BMJ Open 9:5, pages e028321.
Crossref
Crossref
Elizabeth A. Phipps, Ravi Thadhani, Thomas Benzing & S. Ananth Karumanchi. (2019) Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nature Reviews Nephrology 15:5, pages 275-289.
Crossref
Crossref
Anita Virtanen, Outi Huttala, Kati Tihtonen, Tarja Toimela, Tuula Heinonen & Jukka Uotila. (2018) Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesis/angiogenesis test. Angiogenesis 22:1, pages 67-74.
Crossref
Crossref
. (2019) ACOG. Obstetrics & Gynecology 133:1, pages 1-1.
Crossref
Crossref
Ritu Mogra. (2018) Screening and prevention of pre‐term pre‐eclampsia – A prime time to act. Australasian Journal of Ultrasound in Medicine 21:4, pages 187-190.
Crossref
Crossref
Jacqueline G. Parchem, Keizo Kanasaki, Megumi Kanasaki, Hikaru Sugimoto, Liang Xie, Yuki Hamano, Soo Bong Lee, Vincent H. Gattone, Samuel Parry, Jerome F. Strauss, Vesna D. Garovic, Thomas F. McElrath, Karen H. Lu, Baha M. Sibai, Valerie S. LeBleu, Peter Carmeliet & Raghu Kalluri. (2018) Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. Journal of Clinical Investigation 128:11, pages 5008-5017.
Crossref
Crossref
Trung Huu Nguyen, Thanh Cong Bui, Tuan Minh Vo, Quan Minh Tran, Loan Thi-Thanh Luu & Tai Duy Nguyen. (2018) Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam. Pregnancy Hypertension 14, pages 37-42.
Crossref
Crossref
Priyanka Garg, Ashok Kumar Jaryal, Garima Kachhawa, Kishore Kumar Deepak & Alka Kriplani. (2018) Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia. Pregnancy Hypertension 14, pages 245-251.
Crossref
Crossref
Tiina Jääskeläinen, Seppo Heinonen, Esa Hämäläinen, Kari Pulkki, Jarkko Romppanen & Hannele Laivuori. (2018) Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort. Pregnancy Hypertension 14, pages 252-259.
Crossref
Crossref
Nandor Gabor Than, Roberto Romero, Adi Laurentiu Tarca, Katalin Adrienna Kekesi, Yi Xu, Zhonghui Xu, Kata Juhasz, Gaurav Bhatti, Ron Joshua Leavitt, Zsolt Gelencser, Janos Palhalmi, Tzu Hung Chung, Balazs Andras Gyorffy, Laszlo Orosz, Amanda Demeter, Anett Szecsi, Eva Hunyadi-Gulyas, Zsuzsanna Darula, Attila Simor, Katalin Eder, Szilvia Szabo, Vanessa Topping, Haidy El-Azzamy, Christopher LaJeunesse, Andrea Balogh, Gabor Szalai, Susan Land, Olga Torok, Zhong Dong, Ilona Kovalszky, Andras Falus, Hamutal Meiri, Sorin Draghici, Sonia S. Hassan, Tinnakorn Chaiworapongsa, Manuel Krispin, Martin Knöfler, Offer Erez, Graham J. Burton, Chong Jai Kim, Gabor Juhasz & Zoltan Papp. (2018) Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia. Frontiers in Immunology 9.
Crossref
Crossref
Tal Rafaeli-Yehudai, Majdi Imterat, Amos Douvdevani, Dan Tirosh, Neta Benshalom-Tirosh, Salvatore Andrea Mastrolia, Ruthy Beer-Weisel, Vered Klaitman, Reut Riff, Shirley Greenbaum, Alex Alioshin, Gal Rodavsky Hanegbi, Giuseppe Loverro, Mariana Rita Catalano & Offer Erez. (2018) Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation. PLOS ONE 13:7, pages e0200360.
Crossref
Crossref
Arif M. Yusuf, Alyssa Kahane & Joel G. Ray. (2018) First and Second Trimester Serum sFlt-1/PlGF Ratio and Subsequent Preeclampsia: A Systematic Review. Journal of Obstetrics and Gynaecology Canada 40:5, pages 618-626.
Crossref
Crossref
Swati AgrawalAna Sofia CerdeiraChristopher RedmanManu Vatish. (2018) Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia. Hypertension 71:2, pages 306-316.
Crossref
Crossref
Kathryn J. Gray, Richa Saxena & S. Ananth Karumanchi. (2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. American Journal of Obstetrics and Gynecology 218:2, pages 211-218.
Crossref
Crossref
Fernanda Rodrigues Helmo, Angela Maria Moed Lopes, Anna Cecília Dias Maciel Carneiro, Carolina Guissoni Campos, Polyana Barbosa Silva, Maria Luíza Gonçalves dos Reis Monteiro, Laura Penna Rocha, Marlene Antônia dos Reis, Renata Margarida Etchebehere, Juliana Reis Machado & Rosana Rosa Miranda Corrêa. (2018) Angiogenic and antiangiogenic factors in preeclampsia. Pathology - Research and Practice 214:1, pages 7-14.
Crossref
Crossref
Holger Stepan & Janine Hoffmann. 2018. Preeclampsia. Preeclampsia
175
198
.
Tinnakorn Chaiworapongsa, Roberto Romero, Offer Erez, Adi L. Tarca, Agustin Conde-Agudelo, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan, Lami Yeo & Steven J. Korzeniewski. (2017) The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). American Journal of Obstetrics and Gynecology 217:6, pages 682.e1-682.e13.
Crossref
Crossref
Sebastian Kwiatkowski, Barbara Dołegowska, Ewa Kwiatkowska, Rafał Rzepka, Natalia Marczuk, Beata Loj & Andrzej Torbè. (2017) Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. Journal of Perinatal Medicine 45:7, pages 793-802.
Crossref
Crossref
Julia M. Santos, Jung-A. Park, Aby Joiakim, David A. Putt, Robert N. Taylor & Hyesook Kim. (2017) The role of soluble epoxide hydrolase in preeclampsia. Medical Hypotheses 108, pages 81-85.
Crossref
Crossref
Fernanda Regina Giachini, Carlos Galaviz-Hernandez, Alicia E. Damiano, Marta Viana, Angela Cadavid, Patricia Asturizaga, Enrique Teran, Sonia Clapes, Martin Alcala, Julio Bueno, María Calderón-Domínguez, María P. Ramos, Victor Vitorino Lima, Martha Sosa-Macias, Nora Martinez, James M. Roberts & Carlos Escudero. (2017) Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries. Current Hypertension Reports 19:10.
Crossref
Crossref
Ami Ashar-Patel, Yasin Kaymaz, Augustine Rajakumar, Jeffrey A. Bailey, S. Ananth Karumanchi & Melissa J. Moore. (2017) FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia. Scientific Reports 7:1.
Crossref
Crossref
Roberto Romero, Offer Erez, Maik Hüttemann, Eli Maymon, Bogdan Panaitescu, Agustin Conde-Agudelo, Percy Pacora, Bo Hyun Yoon & Lawrence I. Grossman. (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology 217:3, pages 282-302.
Crossref
Crossref
Offer Erez, Roberto Romero, Eli Maymon, Piya Chaemsaithong, Bogdan Done, Percy Pacora, Bogdan Panaitescu, Tinnakorn Chaiworapongsa, Sonia S. Hassan & Adi L. Tarca. (2017) The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 12:7, pages e0181468.
Crossref
Crossref
Roberto Romero, Offer Erez, Eli Maymon, Piya Chaemsaithong, Zhonghui Xu, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Done, Sonia S. Hassan & Adi L. Tarca. (2017) The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. American Journal of Obstetrics and Gynecology 217:1, pages 67.e1-67.e21.
Crossref
Crossref
Takuji Tomimatsu, Kazuya Mimura, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2016) Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertension Research 40:4, pages 305-310.
Crossref
Crossref
Carlos A. Labarrere, Hector L. DiCarlo, Elaine Bammerlin, James W. Hardin, Yeon M. Kim, Piya Chaemsaithong, David M. Haas, Ghassan S. Kassab & Roberto Romero. (2017) Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. American Journal of Obstetrics and Gynecology 216:3, pages 287.e1-287.e16.
Crossref
Crossref
Ilona Hromadnikova, Katerina Kotlabova, Katarina Ivankova & Ladislav Krofta. (2017) First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLOS ONE 12:2, pages e0171756.
Crossref
Crossref
Roberto Romero, Offer Erez, Eli Maymon & Percy Pacora. (2017) Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?. American Journal of Obstetrics and Gynecology 216:2, pages 89-94.
Crossref
Crossref
Akihide Ohkuchi, Chikako Hirashima, Kayo Takahashi, Hirotada Suzuki & Shigeki Matsubara. (2016) Prediction and prevention of hypertensive disorders of pregnancy. Hypertension Research 40:1, pages 5-14.
Crossref
Crossref
Sarosh Rana & S. Ananth Karumanchi. 2017. Fetal and Neonatal Physiology. Fetal and Neonatal Physiology
1724
1732.e2
.
S.A. Karumanchi. 2017. Biomarkers of Kidney Disease. Biomarkers of Kidney Disease
555
594
.
Carine Munaut, Linda Tebache, Silvia Blacher, Agnès Noël, Michelle Nisolle & Frédéric Chantraine. (2016) Dysregulated circulating miRNAs in preeclampsia. Biomedical Reports 5:6, pages 686-692.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Min Zhao, Yongxiang Yin, Jia Wei, Man Wu, Chaokuan Yang & Qi Chen. (2016) Trophoblastic debris extruded from hydatidiform molar placentae activates endothelial cells: Possible relevance to the pathogenesis of preeclampsia. Placenta 45, pages 42-49.
Crossref
Crossref
Juan Yang, Michelle Pearl, Gerald N. DeLorenze, Roberto Romero, Zhong Dong, Laura Jelliffe-Pawlowski, Robert Currier, Monica Flessel & Martin Kharrazi. (2016) Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors. American Journal of Obstetrics and Gynecology 215:3, pages 359.e1-359.e9.
Crossref
Crossref
E. Ferrazzi, S. Zullino, T. Stampalija, C. Vener, P. Cavoretto, M. T. Gervasi, P. Vergani, F. Mecacci, L. Marozio, G. Oggè, P. Algeri, A. Ruffatti, S. Milani & T. Todros. (2016) Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. Ultrasound in Obstetrics & Gynecology 48:2, pages 224-231.
Crossref
Crossref
Stefania Triunfo, Francesca Crovetto, Fatima Crispi, Victor Rodriguez-Sureda, Carmen Dominguez, Alfons Nadal, Anna Peguero, Eduard Gratacos & Francesc Figueras. (2016) Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia. Placenta 42, pages 44-50.
Crossref
Crossref
Alejandro Rodriguez, Methodius G. Tuuli & Anthony O. Odibo. (2016) First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction. Clinics in Laboratory Medicine 36:2, pages 331-351.
Crossref
Crossref
Steven J. Korzeniewski, Roberto Romero, Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan & Lami Yeo. (2016) Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. American Journal of Obstetrics and Gynecology 214:5, pages 629.e1-629.e17.
Crossref
Crossref
Radwa Marawan AbdelHalim, Dalia Ibrahim Ramadan, Reham Zeyada, Ahmed Soliman Nasr & Iman Atef Mandour. (2016) Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study. Molecular Diagnosis & Therapy 20:2, pages 135-149.
Crossref
Crossref
Carlos A. Escudero, Kurt Herlitz, Felipe Troncoso, Jesenia Acurio, Claudio Aguayo, James M. Roberts, Grace Truong, Gregory Duncombe, Gregory Rice & Carlos Salomon. (2016) Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies. Frontiers in Physiology 7.
Crossref
Crossref
Marwa Ben Ali Gannoun, Séverine Bourrelly, Nozha Raguema, Hedia Zitouni, Eva Nouvellon, Wided Maleh, Afraa Brahim Chemili, Raja Elfeleh, Wassim Almawi, Touhami Mahjoub & Jean-Christophe Gris. (2016) Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia. Cytokine 79, pages 1-6.
Crossref
Crossref
Carmen Rădulescu, Anca Bacârea, Adina Huțanu, Rozalia Gabor & Minodora Dobreanu. (2016) Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia. Mediators of Inflammation 2016, pages 1-8.
Crossref
Crossref
A. Margossian, C. Boisson-Gaudin, F. Subtil, R.-C. Rudigoz, G. Dubernard, F. Allias & C. Huissoud. (2016) Impact du retard de croissance intra-utérin sur la concentration sérique maternelle du PlGF (Placental Growth Factor) : une étude cas-témoin. Gynécologie Obstétrique & Fertilité 44:1, pages 23-28.
Crossref
Crossref
Mimi Y. Kim, Jill P. Buyon, Marta M. Guerra, Sarosh Rana, Dongsheng Zhang, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, T. Flint Porter, Joan T. Merrill, Mary D. Stephenson, Qi Gao, S. Ananth Karumanchi & Jane E. Salmon. (2016) Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. American Journal of Obstetrics and Gynecology 214:1, pages 108.e1-108.e14.
Crossref
Crossref
Joo-Yeon Kim & Yeon Mee Kim. (2015) Acute Atherosis of the Uterine Spiral Arteries: Clinicopathologic Implications. Journal of Pathology and Translational Medicine 49:6, pages 462-471.
Crossref
Crossref
P.E. Zozzaro-Smith, M.E. Bushway, S.A. Gerber, D. Hebert, E.K. Pressman, E.M. Lord, R.K. Miller & S.P. Murphy. (2015) Whole mount immunofluorescence analysis of placentas from normotensive versus preeclamptic pregnancies. Placenta 36:11, pages 1310-1317.
Crossref
Crossref
Gaea S. Moore, Amanda A. Allshouse, Virginia D. Winn, Henry L. Galan & Kent D. Heyborne. (2015) Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5:4, pages 280-286.
Crossref
Crossref
Pensée Wu, Caroline van den Berg, Zarko Alfirevic, Shaughn O’Brien, Maria Röthlisberger, Philip Baker, Louise Kenny, Karolina Kublickiene & Johannes Duvekot. (2015) Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences 16:9, pages 23035-23056.
Crossref
Crossref
Yuxiu Liu, Yang Zhao, Ailing Yu, Bin Zhao, Yufang Gao & Haitao Niu. (2015) Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Archives of Gynecology and Obstetrics 292:3, pages 507-518.
Crossref
Crossref
Ignacio Herraiz, Elisa Simón, Paula Gómez-Arriaga, José Martínez-Moratalla, Antonio García-Burguillo, Elena Jiménez & Alberto Galindo. (2015) Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. International Journal of Molecular Sciences 16:8, pages 19009-19026.
Crossref
Crossref
Lene G. Rasmussen, Jacob A. Lykke & Anne C. Staff. (2015) Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstetricia et Gynecologica Scandinavica 94:8, pages 820-832.
Crossref
Crossref
Anshul Jadli, Nitika Sharma, Kaizad Damania, Purnima Satoskar, Vandana Bansal, Kanjaksha Ghosh & Shrimati Shetty. (2015) Promising prognostic markers of Preeclampsia: New avenues in waiting. Thrombosis Research 136:2, pages 189-195.
Crossref
Crossref
Letícia Lemos Jardim, Danyelle Romana Alves Rios, Luíza Oliveira Perucci, Lirlândia Pires de Sousa, Karina Braga Gomes & Luci Maria S. Dusse. (2015) Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?. Clinica Chimica Acta 447, pages 34-38.
Crossref
Crossref
Melissa I. March, Carl Geahchan, Julia Wenger, Nandini Raghuraman, Anders Berg, Hamish Haddow, Bri Ann Mckeon, Rulx Narcisse, Jean Louis David, Jennifer Scott, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLOS ONE 10:5, pages e0126815.
Crossref
Crossref
Gabor Szalai, Roberto Romero, Tinnakorn Chaiworapongsa, Yi Xu, Bing Wang, Hyunyoung Ahn, Zhonghui Xu, Po Jen Chiang, Birgitta Sundell, Rona Wang, Yang Jiang, Olesya Plazyo, Mary Olive, Adi L. Tarca, Zhong Dong, Faisal Qureshi, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2015) Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice. PLOS ONE 10:4, pages e0119547.
Crossref
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Crossref
H. Stepan, I. Herraiz, D. Schlembach, S. Verlohren, S. Brennecke, F. Chantraine, E. Klein, O. Lapaire, E. Llurba, A. Ramoni, M. Vatish, D. Wertaschnigg & A. Galindo. (2015)
Implementation of the
sFlt
‐1/
PlGF
ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
. Ultrasound in Obstetrics & Gynecology 45:3, pages 241-246.
Crossref
Crossref
A. A. Baschat. (2015) First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention. Ultrasound in Obstetrics & Gynecology 45:2, pages 119-129.
Crossref
Crossref
Agustin Conde-Agudelo, Roberto Romero & James M. Roberts. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
221
251
.
Ilona Hromadnikova, Katerina Kotlabova, Lucie Hympanova, Jindrich Doucha & Ladislav Krofta. (2014) First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension. PLoS ONE 9:12, pages e113735.
Crossref
Crossref
Johannes Stubert, Stefanie Ullmann, Michael Bolz, Thomas Külz, Max Dieterich, Dagmar-Ulrike Richter & Toralf Reimer. (2014) Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis. BMC Pregnancy and Childbirth 14:1.
Crossref
Crossref
Gabor Szalai, Yi Xu, Roberto Romero, Tinnakorn Chaiworapongsa, Zhonghui Xu, Po Jen Chiang, Hyunyoung Ahn, Birgitta Sundell, Olesya Plazyo, Yang Jiang, Mary Olive, Bing Wang, Suzanne M. Jacques, Faisal Qureshi, Adi L. Tarca, Offer Erez, Zhong Dong, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2014) In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy. PLoS ONE 9:11, pages e110867.
Crossref
Crossref
Aki Maebayashi Asanuma, Tatsuo Yamamoto, Hiromitu Azuma, Erina Kato, Noriko Yamamoto, Takayuki Murase, Fumihisa Chishima & Manami Suzuki. (2014) Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of. Journal of Obstetrics and Gynaecology Research 40:10, pages 2095-2103.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Steven J. Korzeniewski, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 2: prediction, prevention and management. Nature Reviews Nephrology 10:9, pages 531-540.
Crossref
Crossref
L. Velauthar, M. N. Plana, M. Kalidindi, J. Zamora, B. Thilaganathan, S. E. Illanes, K. S. Khan, J. Aquilina & S. Thangaratinam. (2014) First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women. Ultrasound in Obstetrics & Gynecology 43:5, pages 500-507.
Crossref
Crossref
Torre L. Halscott, Patrick S. Ramsey & Uma M. Reddy. (2014) First trimester screening cannot predict adverse outcomes yet. Prenatal Diagnosis, pages n/a-n/a.
Crossref
Crossref
Melanie Griffin & Andrew H Shennan. (2014) Clinical applications of biomarkers in preeclampsia. Biomarkers in Medicine 8:4, pages 459-470.
Crossref
Crossref
Stefan C. Kane, Fabricio Da Silva Costa & Shaun P. Brennecke. (2014) New directions in the prediction of pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology 54:2, pages 101-107.
Crossref
Crossref
Zeynep Alpay Savasan, Luis F. Goncalves & Ray O. Bahado-Singh. (2014) Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease. Seminars in Perinatology 38:3, pages 167-176.
Crossref
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
Crossref
JIMMY ESPINOZA. (2014) ANGIOGENIC IMBALANCES IN THE PATHOGENESIS OF PREGNANCY COMPLICATIONS. Fetal and Maternal Medicine Review 25:1, pages 42-58.
Crossref
Crossref
Henning Hagmann, Verena Bossung, Abdel Ali Belaidi, Alexander Fridman, S. Ananth Karumanchi, Ravi Thadhani, Bernhard Schermer, Peter Mallmann, Guenter Schwarz, Thomas Benzing & Paul T. Brinkkoetter. (2014) Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination. PLoS ONE 9:1, pages e85258.
Crossref
Crossref
Carlotta Montagnoli. (2014) Preeclampsia: Definitions, screening tools and diagnostic criteria in the supersonic era. World Journal of Obstetrics and Gynecology 3:3, pages 98.
Crossref
Crossref
William Mifsud & Neil J. Sebire. (2014) Placental Pathology in Early-Onset and Late-Onset Fetal Growth Restriction. Fetal Diagnosis and Therapy 36:2, pages 117-128.
Crossref
Crossref
Attila Molvarec, Nóra Gullai, Balázs Stenczer, Gergely Fügedi, Bálint Nagy & János Rigó Jr. (2013) Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study. BMC Pregnancy and Childbirth 13:1.
Crossref
Crossref
S. Zamudio, O. Kovalenko, L. Echalar, T. Torricos, A. Al-Khan, M. Alvarez & N.P. Illsley. (2013) Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy. Placenta 34:12, pages 1170-1176.
Crossref
Crossref
Demetrios Rizos, Makarios Eleftheriades, Gregory Karampas, Myrto Rizou, Alexander Haliassos, Dimitrios Hassiakos & Nikolaos Vitoratos. (2013) Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. European Journal of Obstetrics & Gynecology and Reproductive Biology 171:2, pages 225-230.
Crossref
Crossref
Valerie A. Holmes, Ian S. Young, Christopher C. Patterson, Michael J.A. Maresh, Donald W.M. Pearson, James D. Walker & David R. McCance. (2013) The Role of Angiogenic and Antiangiogenic Factors in the Second Trimester in the Prediction of Preeclampsia in Pregnant Women With Type 1 Diabetes. Diabetes Care 36:11, pages 3671-3677.
Crossref
Crossref
Arvind Goel & Sarosh Rana. (2013) Angiogenic factors in preeclampsia. Current Opinion in Nephrology & Hypertension 22:6, pages 643-650.
Crossref
Crossref
Lauren Anton, Anthony O. Olarerin-George, Nadav Schwartz, Sindhu Srinivas, Jamie Bastek, John B. Hogenesch & Michal A. Elovitz. (2013) miR-210 Inhibits Trophoblast Invasion and Is a Serum Biomarker for Preeclampsia. The American Journal of Pathology 183:5, pages 1437-1445.
Crossref
Crossref
Sarah Thissier-Levy, Isabelle Boucoiran, Zhong-Cheng Luo, Anne-Monique Nuyt, Pierre Julien, William D. Fraser & Francois Audibert. (2013) Endostatin levels and the risk of subsequent preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 170:2, pages 396-400.
Crossref
Crossref
Sun Min Kim, Joong Shin Park, Errol R. Norwitz, Hee Jung Jung, Byoung Jae Kim, Chan-Wook Park & Jong Kwan Jun. (2013) Circulating Levels of Neutrophil Gelatinase–Associated Lipocalin (NGAL) Correlate With the Presence and Severity of Preeclampsia. Reproductive Sciences 20:9, pages 1083-1089.
Crossref
Crossref
WT Schnettler, D Dukhovny, J Wenger, S Salahuddin, SJ Ralston & S Rana. (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1224-1232.
Crossref
Crossref
L Myatt, RG Clifton, JM Roberts, CY Spong, RJ Wapner, JM ThorpJrJr, BM Mercer, AM Peaceman, SM Ramin, MW Carpenter, A Sciscione, JE Tolosa, G Saade, Y Sorokin & GD Anderson. (2013) Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1183-1191.
Crossref
Crossref
T. F. T. Antonios, V. Nama, D. Wang & I. T. Manyonda. (2013) Microvascular Remodelling in Preeclampsia: Quantifying Capillary Rarefaction Accurately and Independently Predicts Preeclampsia. American Journal of Hypertension 26:9, pages 1162-1169.
Crossref
Crossref
Enrico Ferrazzi, Tamara Stampalija, Karina Makarenko & Daniela Casati. (2013) Fetal Growth Restriction (FGR)—Fetal Evaluation and Antepartum Intervention. Current Obstetrics and Gynecology Reports 2:2, pages 112-121.
Crossref
Crossref
Srujana Polsani, Elizabeth Phipps & Belinda Jim. (2013) Emerging New Biomarkers of Preeclampsia. Advances in Chronic Kidney Disease 20:3, pages 271-279.
Crossref
Crossref
Nóra Gullai, Balázs Stenczer, Attila Molvarec, Gergely Fügedi, Zoltán Veresh, Bálint Nagy & János RigóJrJr. (2013) Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy. Hypertension Research 36:5, pages 457-462.
Crossref
Crossref
Sanjib Kumar Ghosh, Shashi Raheja, Anita Tuli, Chitra Raghunandan & Sneh Agarwal. (2012) Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?. Archives of Gynecology and Obstetrics 287:5, pages 865-873.
Crossref
Crossref
Amy E. Whitten, Roberto Romero, Steven J. Korzeniewski, Adi L. Tarca, Alyse G. Schwartz, Lami Yeo, Zhong Dong, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2013) Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. American Journal of Obstetrics and Gynecology 208:4, pages 310.e1-310.e11.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Juan Pedro Kusanovic, Eleazar Soto, Jennifer Lam, Zhong Dong, Nandor G. Than, Lami Yeo, Edgar Hernandez-Andrade, Agustín Conde-Agudelo & Sonia S. Hassan. (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. American Journal of Obstetrics and Gynecology 208:4, pages 287.e1-287.e15.
Crossref
Crossref
Sanjib Kumar Ghosh, Shashi Raheja, Anita Tuli, Chitra Raghunandan & Sneh Agarwal. (2013) Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women. Journal of the American Society of Hypertension 7:2, pages 137-148.
Crossref
Crossref
Jamie A. Bastek & Michal A. Elovitz. (2013) The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia. Fertility and Sterility 99:4, pages 1117-1123.
Crossref
Crossref
Sun K. Kim, Roberto Romero, Zeynep A. Savasan, Yi Xu, Zhong Dong, Deug‐Chan Lee, Lami Yeo, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2012) Endoglin in Amniotic Fluid as a Risk Factor for the Subsequent Development of Bronchopulmonary Dysplasia. American Journal of Reproductive Immunology 69:2, pages 105-123.
Crossref
Crossref
HERBERT VALENSISE, GIAN PAOLO NOVELLI & BARBARA VASAPOLLO. (2013) PRE-ECLAMPSIA: ONE NAME, TWO CONDITIONS – THE CASE FOR EARLY AND LATE DISEASE BEING DIFFERENT. Fetal and Maternal Medicine Review 24:1, pages 32-37.
Crossref
Crossref
Tatsuo Yamamoto, Fumihisa Chishima & Masahiko Matsuura. (2013) Prediction of preeclampsia using angiogenic and antiangiogenic factors. Hypertension Research in Pregnancy 1:2, pages 66-70.
Crossref
Crossref
Mahmoud Fathy Hassan, Nancy Mohamed Ali Rund & Ahmed Husseiny Salama. (2013) An Elevated Maternal Plasma Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio at Midtrimester Is a Useful Predictor for Preeclampsia. Obstetrics and Gynecology International 2013, pages 1-8.
Crossref
Crossref
Kirk P. Conrad & S. Ananth Karumanchi. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney
2689
2761
.
Jeanne Sibiude, Jean Guibourdenche, Marie-Danielle Dionne, Camille Le Ray, Olivia Anselem, Raphaël Serreau, François Goffinet & Vassilis Tsatsaris. (2012) Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction. PLoS ONE 7:11, pages e50208.
Crossref
Crossref
Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi I. Thadhani & S. Ananth Karumanchi. (2012) Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS ONE 7:10, pages e48259.
Crossref
Crossref
Christopher T. Banek, Ashley J. Bauer, Anne Gingery & Jeffrey S. Gilbert. (2012) Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 303:6, pages R658-R664.
Crossref
Crossref
Sarosh RanaMichele R. HackerAnna Merport ModestSaira SalahuddinKee-Hak LimStefan VerlohrenFrank H. PerschelS. Ananth Karumanchi. (2012) Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia. Hypertension 60:2, pages 451-458.
Crossref
Crossref
Samantha Weed, Jamie A. Bastek, Lauren Anton, Michal A. Elovitz, Samuel Parry & Sindhu K. Srinivas. (2012) Examining the correlation between placental and serum placenta growth factor in preeclampsia. American Journal of Obstetrics and Gynecology 207:2, pages 140.e1-140.e6.
Crossref
Crossref
B. Mikat, A. Gellhaus, N. Wagner, C. Birdir, R. Kimmig & A. Köninger. (2012) Early Detection of Maternal Risk for Preeclampsia. ISRN Obstetrics and Gynecology 2012, pages 1-7.
Crossref
Crossref
Robert W. PowersJames M. RobertsDaniel A. PlymireDominick PucciSaul A. DatwylerDon M. LairdDavid C. SoginArun JeyabalanCarl A. HubelRobin E. Gandley. (2012) Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm Preeclampsia. Hypertension 60:1, pages 239-246.
Crossref
Crossref
P. H. Andraweera, G. A. Dekker & C. T. Roberts. (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Human Reproduction Update 18:4, pages 436-457.
Crossref
Crossref
CE Kleinrouweler, MMJ Wiegerinck, C Ris‐Stalpers, PMM Bossuyt, JAM van der Post, P von Dadelszen, BWJ Mol & E Pajkrt. (2012) Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology 119:7, pages 778-787.
Crossref
Crossref
Marianne Coolman, Sarah Timmermans, Christianne J. M. de Groot, Henk Russcher, Jan Lindemans, Albert Hofman, Anneke J. Geurts-Moespot, Fred C. G. J. Sweep, Vincent V. W. Jaddoe & Eric A. P. Steegers. (2012) Angiogenic and Fibrinolytic Factors in Blood During the First Half of Pregnancy and Adverse Pregnancy Outcomes. Obstetrics & Gynecology 119:6, pages 1190-1200.
Crossref
Crossref
G. Di Lorenzo, M. Ceccarello, V. Cecotti, L. Ronfani, L. Monasta, L. Vecchi Brumatti, M. Montico & G. D’Ottavio. (2012) First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 33:6, pages 495-501.
Crossref
Crossref
Henning Hagmann, Ravi Thadhani, Thomas Benzing, S Ananth Karumanchi & Holger Stepan. (2012) The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry 58:5, pages 837-845.
Crossref
Crossref
Catherine L. Haggerty, Michael E. Seifert, Gong Tang, Jørn Olsen, Debra C. Bass, S. Ananth Karumanchi & Roberta B. Ness. (2012) Second trimester anti-angiogenic proteins and preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 2:2, pages 158-163.
Crossref
Crossref
Eileen R. Fowles, Lorraine O. Walker, C. Nathan Marti, Roberta Jeanne Ruiz, Joel Wommack, Miranda Bryant, SungHun Kim & Gayle M. Timmerman. (2012) Relationships among maternal nutrient intake and placental biomarkers during the 1st trimester in low-income women. Archives of Gynecology and Obstetrics 285:4, pages 891-899.
Crossref
Crossref
Uma PerniCristina SisonVijay SharmaGeri HelsethAmret HawfieldManikkam SuthanthiranPhyllis August. (2012) Angiogenic Factors in Superimposed Preeclampsia. Hypertension 59:3, pages 740-746.
Crossref
Crossref
Sarosh RanaCamille E. PoweSaira SalahuddinStefan VerlohrenFrank H. PerschelRichard J. LevineKee-Hak LimJulia B. WengerRavi ThadhaniS. Ananth Karumanchi. (2012) Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation 125:7, pages 911-919.
Crossref
Crossref
JoonHo LeeRoberto RomeroZhong DongDeug-Chan LeeYi DongPooja MittalTinnakorn ChaiworapongsaSonia S. HassanChong Jai Kim. (2012) Glycogen Phosphorylase Isoenzyme BB Plasma Concentration Is Elevated in Pregnancy and Preterm Preeclampsia. Hypertension 59:2, pages 274-282.
Crossref
Crossref
Stefan Verlohren, Holger Stepan & Ralf Dechend. (2011) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clinical Science 122:2, pages 43-52.
Crossref
Crossref
Stefan Verlohren, Ignacio Herraiz, Olav Lapaire, Dietmar Schlembach, Manfred Moertl, Harald Zeisler, Pavel Calda, Wolfgang Holzgreve, Alberto Galindo, Theresa Engels, Barbara Denk & Holger Stepan. (2012) The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. American Journal of Obstetrics and Gynecology 206:1, pages 58.e1-58.e8.
Crossref
Crossref
Akihide OhkuchiChikako HirashimaShigeki MatsubaraKayo TakahashiYoshio MatsudaMitsuaki Suzuki. (2011) Threshold of Soluble Fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio for the Imminent Onset of Preeclampsia. Hypertension 58:5, pages 859-866.
Crossref
Crossref
Roberto Romero. (2011) Vaginal Progesterone to Reduce the Rate of Preterm Birth and Neonatal Morbidity: A Solution at Last. Women's Health 7:5, pages 501-504.
Crossref
Crossref
Stefanie Bussen & Dieter Bussen. (2010) Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome. Archives of Gynecology and Obstetrics 284:3, pages 551-557.
Crossref
Crossref
Jenni K. Ranta, Kaisa Raatikainen, Jarkko Romppanen, Kari Pulkki & Seppo Heinonen. (2011) Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. European Journal of Obstetrics & Gynecology and Reproductive Biology 157:1, pages 48-52.
Crossref
Crossref
Camille E. PoweRichard J. LevineS. Ananth Karumanchi. (2011) Preeclampsia, a Disease of the Maternal Endothelium. Circulation 123:24, pages 2856-2869.
Crossref
Crossref
Displaying 200 of 227 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list